Can Pregnant Women Take Allergy Medication?
Yes, pregnant women can safely take certain allergy medications, specifically second-generation oral antihistamines (cetirizine or loratadine) and intranasal corticosteroids (budesonide, fluticasone, or mometasone) at recommended doses.
Recommended First-Line Treatments
Intranasal Corticosteroids (Preferred)
Intranasal corticosteroids are the most effective option and should be considered first-line therapy for moderate to severe allergic rhinitis during pregnancy 1. The safest options include:
- Budesonide - drug of choice with the most favorable safety profile 2
- Fluticasone propionate and fluticasone furoate - safe at recommended therapeutic doses 3
- Mometasone - safe at recommended doses 3
- Beclomethasone - acceptable alternative 4
These medications work through minimal systemic absorption, making them safer than oral alternatives. Studies of over 53 pregnant women using fluticasone showed no detectable influence on maternal cortisol, fetal growth, or pregnancy outcomes 1. Avoid intranasal triamcinolone, which has been associated with respiratory tract defects 3.
Oral Antihistamines (Alternative or Adjunct)
For mild disease or when rapid symptom relief is needed 5:
Second-generation antihistamines (preferred):
- Cetirizine - first choice, supported by data from over 186,000 exposures showing no increased risk of major congenital malformations 6
- Loratadine - equally safe, studied in 2,147 pregnant women with no increased teratogenic risk 4
First-generation antihistamines:
- Chlorpheniramine and tripelennamine are safe options based on meta-analysis of 200,000 first-trimester exposures 4, 7
- However, avoid routine use due to sedative and anticholinergic properties 1
What to Avoid
Medications to Avoid During Pregnancy:
- Oral decongestants - may increase risk of fetal gastroschisis and maternal hypertension 1
- Intranasal antihistamines 2
- Leukotriene receptor antagonists (montelukast) - avoid for rhinitis treatment, though can continue for pre-existing asthma if previously effective 1
Treatment Algorithm
Start with non-pharmacologic measures: Hypertonic saline nasal rinses are safe and effective 5
For mild symptoms: Use second-generation oral antihistamines (cetirizine or loratadine)
For moderate-to-severe symptoms: Initiate intranasal corticosteroid (budesonide preferred, then fluticasone or mometasone)
For inadequate control: Continue intranasal corticosteroid; adding oral antihistamines provides minimal additional benefit and is not routinely recommended 8
Timing consideration: For predictable seasonal allergies, start intranasal corticosteroids 1-2 weeks before anticipated pollen season 8
Important Caveats
Trimester-specific considerations: First-trimester use of any medication carries the highest theoretical teratogenic risk, though the medications listed above have not shown increased malformation rates. The risk of undertreated allergic disease must be weighed against medication risks 1.
Consultation: When considering systemic corticosteroids for severe exacerbations (especially after first trimester), consult with the patient's obstetrician 1.
Immunotherapy: If already receiving allergen immunotherapy, continue at the same dose but do not initiate or increase doses during pregnancy due to anaphylaxis risk 1.
Breastfeeding: The recommended medications are compatible with breastfeeding, with less than 1% passing into breast milk. Consider breastfeeding before taking medication to further limit infant exposure 1.
Quality of Evidence
The recommendations prioritize maternal quality of life and symptom control while ensuring fetal safety. While direct studies in pregnancy are limited (evidence level zero for many interventions), extensive population-based cohort data covering over 1.2 million pregnancies support the safety of second-generation antihistamines 6. The intranasal corticosteroid recommendations are based on their minimal systemic absorption and proven efficacy in the general population, with available pregnancy data showing no adverse outcomes 1, 3.